BioWorld Asia

Sep. 3, 2008

European Research Funding Caught in Ethical Controls

BRUSSELS, Belgium - European Union generosity in supporting biotech research is being qualified by persistent concessions to the diversity of ethical views across the EU's 27 member states. (BioWorld International) Read More

Another New CEO Faces Oxford BioMedica Test

Direct Reprogramming Is New Cell Source for Regeneration

Alizyme Cuts to the Bone While Searching for a Deal

Restarted Pharmalink Generates Promising Phase III Data in PPS

Biotechs Ahead of Pharma in '08 New Drug Approvals

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 18, 2025.

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...